In summary, our results provided strong evidence to support an important role of ER-α36-mediated rapid estrogen signaling in maintenance and regulation of ER-positive breast cancer stem/progenitor cells and provided a rational for development of therapeutic approaches to restrict growth of breast cancer stem/progenitor cells by targeting ER-α36. Here, ESR1 is linked to breast carcinoma.